

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 5.35021174 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 5.07903653 |
| 3 | regulation of gene silencing by RNA (GO:0060966) | 4.62588527 |
| 4 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.62588527 |
| 5 | regulation of gene silencing by miRNA (GO:0060964) | 4.62588527 |
| 6 | regulation of translational fidelity (GO:0006450) | 4.54839873 |
| 7 | establishment of apical/basal cell polarity (GO:0035089) | 4.28583328 |
| 8 | regulation of integrin activation (GO:0033623) | 4.24829038 |
| 9 | protein localization to endosome (GO:0036010) | 4.18096859 |
| 10 | response to peptidoglycan (GO:0032494) | 4.02272503 |
| 11 | pre-miRNA processing (GO:0031054) | 3.97405166 |
| 12 | barbed-end actin filament capping (GO:0051016) | 3.97337393 |
| 13 | transcription from mitochondrial promoter (GO:0006390) | 3.96388384 |
| 14 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.96290371 |
| 15 | replication fork processing (GO:0031297) | 3.91572462 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 3.91237563 |
| 17 | apoptotic process involved in morphogenesis (GO:0060561) | 3.86791739 |
| 18 | pinocytosis (GO:0006907) | 3.85777380 |
| 19 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.84136750 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.72253561 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.72253561 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.72253561 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.72253561 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.72253561 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.72253561 |
| 26 | heterochromatin organization (GO:0070828) | 3.71806798 |
| 27 | DNA unwinding involved in DNA replication (GO:0006268) | 3.71657797 |
| 28 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.69872106 |
| 29 | mitochondrial DNA metabolic process (GO:0032042) | 3.68052038 |
| 30 | IMP biosynthetic process (GO:0006188) | 3.56401883 |
| 31 | positive regulation of protein homooligomerization (GO:0032464) | 3.55482733 |
| 32 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.54790968 |
| 33 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.54790968 |
| 34 | nodal signaling pathway (GO:0038092) | 3.53828021 |
| 35 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.53412541 |
| 36 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.51050102 |
| 37 | establishment of monopolar cell polarity (GO:0061162) | 3.51050102 |
| 38 | skin morphogenesis (GO:0043589) | 3.50482857 |
| 39 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.50388321 |
| 40 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.49405509 |
| 41 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.48214490 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.47193973 |
| 43 | trophectodermal cell differentiation (GO:0001829) | 3.47044926 |
| 44 | mitotic nuclear envelope disassembly (GO:0007077) | 3.46648106 |
| 45 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.42976315 |
| 46 | DNA deamination (GO:0045006) | 3.42933041 |
| 47 | base-excision repair (GO:0006284) | 3.42465903 |
| 48 | dosage compensation (GO:0007549) | 3.39853065 |
| 49 | DNA strand renaturation (GO:0000733) | 3.39285953 |
| 50 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.38660007 |
| 51 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.38660007 |
| 52 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.38660007 |
| 53 | negative regulation of interleukin-12 production (GO:0032695) | 3.33230644 |
| 54 | negative regulation of cell cycle arrest (GO:0071157) | 3.33140412 |
| 55 | mitotic G1/S transition checkpoint (GO:0044819) | 3.31765695 |
| 56 | proline metabolic process (GO:0006560) | 3.30686322 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.29152026 |
| 58 | DNA strand elongation (GO:0022616) | 3.27321635 |
| 59 | mitotic sister chromatid segregation (GO:0000070) | 3.26937503 |
| 60 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.24618215 |
| 61 | IMP metabolic process (GO:0046040) | 3.24478179 |
| 62 | G1 DNA damage checkpoint (GO:0044783) | 3.23508652 |
| 63 | macrophage activation involved in immune response (GO:0002281) | 3.23253203 |
| 64 | membrane disassembly (GO:0030397) | 3.22721741 |
| 65 | nuclear envelope disassembly (GO:0051081) | 3.22721741 |
| 66 | positive regulation of chromosome segregation (GO:0051984) | 3.20854136 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 3.16058543 |
| 68 | mRNA cleavage (GO:0006379) | 3.15607660 |
| 69 | embryonic placenta development (GO:0001892) | 3.15379251 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14830720 |
| 71 | apoptotic cell clearance (GO:0043277) | 3.14769258 |
| 72 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.13611887 |
| 73 | regulation of sister chromatid cohesion (GO:0007063) | 3.10267582 |
| 74 | protein localization to kinetochore (GO:0034501) | 3.10188305 |
| 75 | hypotonic response (GO:0006971) | 3.07182197 |
| 76 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.06716034 |
| 77 | nuclear pore organization (GO:0006999) | 3.05902221 |
| 78 | positive regulation of extracellular matrix organization (GO:1903055) | 3.04650409 |
| 79 | low-density lipoprotein particle clearance (GO:0034383) | 3.03431262 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.00885630 |
| 81 | Golgi transport vesicle coating (GO:0048200) | 3.00865607 |
| 82 | COPI coating of Golgi vesicle (GO:0048205) | 3.00865607 |
| 83 | negative regulation of mRNA processing (GO:0050686) | 3.00501130 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 3.00159606 |
| 85 | negative regulation of RNA splicing (GO:0033119) | 2.98921088 |
| 86 | cell adhesion mediated by integrin (GO:0033627) | 2.97489393 |
| 87 | histone arginine methylation (GO:0034969) | 2.96881215 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.95461395 |
| 89 | negative regulation of cell killing (GO:0031342) | 2.95461395 |
| 90 | hemidesmosome assembly (GO:0031581) | 2.95093447 |
| 91 | mannose metabolic process (GO:0006013) | 2.94909855 |
| 92 | oligosaccharide catabolic process (GO:0009313) | 2.93240745 |
| 93 | oxidative demethylation (GO:0070989) | 2.91119578 |
| 94 | basement membrane organization (GO:0071711) | 2.90864198 |
| 95 | telomere maintenance via recombination (GO:0000722) | 2.90471064 |
| 96 | regulation of leukocyte degranulation (GO:0043300) | 2.89746581 |
| 97 | stress fiber assembly (GO:0043149) | 2.88542956 |
| 98 | endodermal cell differentiation (GO:0035987) | 2.88256015 |
| 99 | response to laminar fluid shear stress (GO:0034616) | 2.88250007 |
| 100 | sister chromatid segregation (GO:0000819) | 2.86990883 |
| 101 | regulation of early endosome to late endosome transport (GO:2000641) | 2.86324284 |
| 102 | NIK/NF-kappaB signaling (GO:0038061) | 2.85611354 |
| 103 | apoptotic process involved in development (GO:1902742) | 2.84503729 |
| 104 | termination of RNA polymerase II transcription (GO:0006369) | 2.84358692 |
| 105 | regulation of hippo signaling (GO:0035330) | 2.83664850 |
| 106 | regulation of mast cell degranulation (GO:0043304) | 2.82387439 |
| 107 | nuclear envelope organization (GO:0006998) | 2.80008977 |
| 108 | regulation of protein homooligomerization (GO:0032462) | 2.78853953 |
| 109 | DNA duplex unwinding (GO:0032508) | 2.78334683 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78105589 |
| 111 | DNA geometric change (GO:0032392) | 2.77916677 |
| 112 | regulation of superoxide anion generation (GO:0032928) | 2.77814340 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77197714 |
| 114 | viral mRNA export from host cell nucleus (GO:0046784) | 2.76377908 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.75821650 |
| 116 | cellular extravasation (GO:0045123) | 2.74473968 |
| 117 | regulation of RNA export from nucleus (GO:0046831) | 2.73744688 |
| 118 | nuclear pore complex assembly (GO:0051292) | 2.73472953 |
| 119 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.72321298 |
| 120 | paraxial mesoderm development (GO:0048339) | 2.71912107 |
| 121 | positive regulation of protein oligomerization (GO:0032461) | 2.70564913 |
| 122 | DNA replication initiation (GO:0006270) | 2.69707700 |
| 123 | hyaluronan catabolic process (GO:0030214) | 2.68339005 |
| 124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.66452932 |
| 125 | regulation of protein heterodimerization activity (GO:0043497) | 2.66261797 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.66257122 |
| 127 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65461907 |
| 128 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.64145726 |
| 129 | regulation of podosome assembly (GO:0071801) | 2.63732837 |
| 130 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.63720091 |
| 131 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.63720091 |
| 132 | modulation by symbiont of host cellular process (GO:0044068) | 2.63449664 |
| 133 | mitotic recombination (GO:0006312) | 2.62989891 |
| 134 | glycolipid catabolic process (GO:0019377) | 2.62951997 |
| 135 | detection of other organism (GO:0098543) | 2.62382912 |
| 136 | negative regulation of histone methylation (GO:0031061) | 2.62250425 |
| 137 | glucose 6-phosphate metabolic process (GO:0051156) | 2.62156997 |
| 138 | meiotic chromosome segregation (GO:0045132) | 2.62080849 |
| 139 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.61068891 |
| 140 | regulation of histone H3-K9 methylation (GO:0051570) | 2.60772846 |
| 141 | decidualization (GO:0046697) | 2.60640118 |
| 142 | peptidyl-proline hydroxylation (GO:0019511) | 2.60452180 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.58873570 |
| 144 | negative regulation of mRNA metabolic process (GO:1903312) | 2.58574790 |
| 145 | positive regulation of leukocyte degranulation (GO:0043302) | 2.58539644 |
| 146 | regulation of DNA damage checkpoint (GO:2000001) | 2.58483208 |
| 147 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.57632181 |
| 148 | cell-substrate junction assembly (GO:0007044) | 2.56563509 |
| 149 | amino sugar catabolic process (GO:0046348) | 2.56112373 |
| 150 | translational initiation (GO:0006413) | 2.55440403 |
| 151 | telomere maintenance via telomere lengthening (GO:0010833) | 2.55353040 |
| 152 | myeloid dendritic cell differentiation (GO:0043011) | 2.54704422 |
| 153 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.54189668 |
| 154 | substrate-dependent cell migration (GO:0006929) | 2.53773582 |
| 155 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.53405261 |
| 156 | maternal placenta development (GO:0001893) | 2.52252021 |
| 157 | nuclear envelope reassembly (GO:0031468) | 2.52239070 |
| 158 | mitotic nuclear envelope reassembly (GO:0007084) | 2.52239070 |
| 159 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51709773 |
| 160 | regulation of double-strand break repair (GO:2000779) | 2.51654908 |
| 161 | protein localization to chromosome, centromeric region (GO:0071459) | 2.51233620 |
| 162 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.50640105 |
| 163 | positive regulation of T cell apoptotic process (GO:0070234) | 2.50196902 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.50045468 |
| 165 | regulation of extracellular matrix disassembly (GO:0010715) | 2.49497554 |
| 166 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.49303627 |
| 167 | positive regulation of phagocytosis (GO:0050766) | 2.47767327 |
| 168 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47680678 |
| 169 | response to host (GO:0075136) | 2.47435005 |
| 170 | response to host defenses (GO:0052200) | 2.47435005 |
| 171 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.47435005 |
| 172 | protein hydroxylation (GO:0018126) | 2.47320068 |
| 173 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.46942501 |
| 174 | T-helper 1 type immune response (GO:0042088) | 2.45666369 |
| 175 | detection of bacterium (GO:0016045) | 2.44499344 |
| 176 | positive regulation of receptor recycling (GO:0001921) | 2.43804782 |
| 177 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.42557862 |
| 178 | respiratory burst (GO:0045730) | 2.42364365 |
| 179 | response to progesterone (GO:0032570) | 2.40765658 |
| 180 | cortical actin cytoskeleton organization (GO:0030866) | 2.38918969 |
| 181 | adhesion of symbiont to host (GO:0044406) | 2.37794799 |
| 182 | macrophage differentiation (GO:0030225) | 2.37625403 |
| 183 | regulation of macrophage chemotaxis (GO:0010758) | 2.37456713 |
| 184 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.36898049 |
| 185 | regulation of cholesterol storage (GO:0010885) | 2.36562643 |
| 186 | detection of biotic stimulus (GO:0009595) | 2.35963042 |
| 187 | protein retention in ER lumen (GO:0006621) | 2.35514325 |
| 188 | germinal center formation (GO:0002467) | 2.35111096 |
| 189 | response to thyroid hormone (GO:0097066) | 2.34831884 |
| 190 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.33659966 |
| 191 | membrane raft organization (GO:0031579) | 2.32984976 |
| 192 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.32948464 |
| 193 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.32396170 |
| 194 | venous blood vessel morphogenesis (GO:0048845) | 2.31319311 |
| 195 | granulocyte activation (GO:0036230) | 2.30486145 |
| 196 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.27593628 |
| 197 | regulation of cholesterol homeostasis (GO:2000188) | 2.26626558 |
| 198 | regulation of phagocytosis (GO:0050764) | 2.26403532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.62412712 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.62063267 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.22651571 |
| 4 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.12212840 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.08830322 |
| 6 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.52992319 |
| 7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.51750427 |
| 8 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.38354821 |
| 9 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.38354821 |
| 10 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.38354821 |
| 11 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.34080654 |
| 12 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.32643223 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.31356279 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.30526054 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.28535371 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.24030187 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23330216 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19444758 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.15306620 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.12720904 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10288834 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08775187 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06651601 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.04244277 |
| 25 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.00924093 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.97713644 |
| 27 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.96481350 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92905439 |
| 29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91512360 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90336571 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89569268 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88029061 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85324480 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80306614 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.79278031 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77392179 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.77033757 |
| 38 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.76491438 |
| 39 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.75530256 |
| 40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71616977 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71573921 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69553686 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68764573 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.66621383 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.65409904 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61367513 |
| 47 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.59820664 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58477923 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.58346124 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58240549 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54979292 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.53253295 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52856696 |
| 54 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48448720 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48416801 |
| 56 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.45340163 |
| 57 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.44637710 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44065921 |
| 59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.42792090 |
| 60 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41628584 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41373198 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.41186125 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.40398127 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40335508 |
| 65 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38961858 |
| 66 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38508809 |
| 67 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.37390142 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37153573 |
| 69 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.35608224 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35513404 |
| 71 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.34901917 |
| 72 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.34664939 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33922172 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33568751 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32132607 |
| 76 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.31279369 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30800923 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30558514 |
| 79 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.28974762 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28592131 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.28344763 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28092309 |
| 83 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.27189145 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26942791 |
| 85 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26665773 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26253285 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25495593 |
| 88 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25447234 |
| 89 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25394506 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25054159 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.25028752 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23867845 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23839388 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23390246 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22890424 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22847414 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22803799 |
| 98 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.22610629 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22318113 |
| 100 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.22245616 |
| 101 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21510747 |
| 102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21071676 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21013320 |
| 104 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20079412 |
| 105 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19703533 |
| 106 | * MAF_26560356_Chip-Seq_TH1_Human | 1.19106519 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18932343 |
| 108 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18541974 |
| 109 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.18227611 |
| 110 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.17749704 |
| 111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17267506 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15393389 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15254622 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15254622 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14729913 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14580609 |
| 117 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14303702 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14268980 |
| 119 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14181154 |
| 120 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13708030 |
| 121 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13521288 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12982091 |
| 123 | P68_20966046_ChIP-Seq_HELA_Human | 1.12762855 |
| 124 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12250194 |
| 125 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11869420 |
| 126 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11777522 |
| 127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11675896 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11204786 |
| 129 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10848403 |
| 130 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10843472 |
| 131 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10044977 |
| 132 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09533221 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09110013 |
| 134 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08462827 |
| 135 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.08389169 |
| 136 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.08281210 |
| 137 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.07562815 |
| 138 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07395807 |
| 139 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06712825 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06427687 |
| 141 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.06384657 |
| 142 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05914031 |
| 143 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.05279558 |
| 144 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05276321 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05006069 |
| 146 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04955722 |
| 147 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04742768 |
| 148 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04310449 |
| 149 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04076832 |
| 150 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04076613 |
| 151 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03952773 |
| 152 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.03092013 |
| 153 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.02707369 |
| 154 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02610624 |
| 155 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.02599749 |
| 156 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01896268 |
| 157 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01740432 |
| 158 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01307824 |
| 159 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01073231 |
| 160 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00041919 |
| 161 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99738243 |
| 162 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99361888 |
| 163 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98993278 |
| 164 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97849409 |
| 165 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97532262 |
| 166 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97411074 |
| 167 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.96045922 |
| 168 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95785596 |
| 169 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.95600880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.50667481 |
| 2 | MP0008057_abnormal_DNA_replication | 3.28316757 |
| 3 | MP0010030_abnormal_orbit_morphology | 3.16931336 |
| 4 | MP0009840_abnormal_foam_cell | 3.01317072 |
| 5 | MP0005076_abnormal_cell_differentiation | 2.86211557 |
| 6 | MP0005451_abnormal_body_composition | 2.77355306 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.74970330 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.57704531 |
| 9 | MP0010094_abnormal_chromosome_stability | 2.56818400 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.55751615 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.53140386 |
| 12 | MP0004233_abnormal_muscle_weight | 2.40367703 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.37625613 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.31905103 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.31856027 |
| 16 | MP0003077_abnormal_cell_cycle | 2.20813506 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.19724972 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.15451253 |
| 19 | MP0002419_abnormal_innate_immunity | 2.15262953 |
| 20 | MP0010307_abnormal_tumor_latency | 2.08647058 |
| 21 | MP0008260_abnormal_autophagy | 2.04623522 |
| 22 | MP0003303_peritoneal_inflammation | 1.98348495 |
| 23 | MP0004510_myositis | 1.95164358 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.93181668 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.89486612 |
| 26 | MP0001730_embryonic_growth_arrest | 1.84821283 |
| 27 | MP0003091_abnormal_cell_migration | 1.84800900 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.83326120 |
| 29 | MP0003567_abnormal_fetal_cardiomyocyte | 1.81371813 |
| 30 | MP0003279_aneurysm | 1.78058829 |
| 31 | MP0005171_absent_coat_pigmentation | 1.77942049 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.77407239 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.76548741 |
| 34 | MP0008932_abnormal_embryonic_tissue | 1.76276630 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.73693433 |
| 36 | MP0009785_altered_susceptibility_to | 1.73229048 |
| 37 | MP0003075_altered_response_to | 1.72120614 |
| 38 | MP0001697_abnormal_embryo_size | 1.71784904 |
| 39 | MP0000350_abnormal_cell_proliferation | 1.71183255 |
| 40 | MP0004197_abnormal_fetal_growth/weight/ | 1.70479280 |
| 41 | MP0004272_abnormal_basement_membrane | 1.66995884 |
| 42 | MP0000604_amyloidosis | 1.65739723 |
| 43 | MP0005025_abnormal_response_to | 1.65541235 |
| 44 | MP0002086_abnormal_extraembryonic_tissu | 1.64987397 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.64632139 |
| 46 | MP0006054_spinal_hemorrhage | 1.64096962 |
| 47 | MP0003724_increased_susceptibility_to | 1.62691170 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.62608922 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.62608922 |
| 50 | MP0002084_abnormal_developmental_patter | 1.60189824 |
| 51 | MP0005380_embryogenesis_phenotype | 1.59764458 |
| 52 | MP0001672_abnormal_embryogenesis/_devel | 1.59764458 |
| 53 | MP0004947_skin_inflammation | 1.59496011 |
| 54 | MP0001293_anophthalmia | 1.59153164 |
| 55 | MP0001958_emphysema | 1.57991826 |
| 56 | MP0004133_heterotaxia | 1.55896257 |
| 57 | MP0002085_abnormal_embryonic_tissue | 1.55524716 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.53951502 |
| 59 | MP0003123_paternal_imprinting | 1.49005328 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.48173401 |
| 61 | MP0001790_abnormal_immune_system | 1.48083084 |
| 62 | MP0005387_immune_system_phenotype | 1.48083084 |
| 63 | MP0005000_abnormal_immune_tolerance | 1.46842527 |
| 64 | MP0005023_abnormal_wound_healing | 1.43715416 |
| 65 | MP0003984_embryonic_growth_retardation | 1.43598730 |
| 66 | MP0003119_abnormal_digestive_system | 1.43123630 |
| 67 | MP0003329_amyloid_beta_deposits | 1.42924761 |
| 68 | MP0003436_decreased_susceptibility_to | 1.41773820 |
| 69 | MP0002088_abnormal_embryonic_growth/wei | 1.41355482 |
| 70 | MP0008877_abnormal_DNA_methylation | 1.38603336 |
| 71 | MP0009053_abnormal_anal_canal | 1.34228916 |
| 72 | MP0002080_prenatal_lethality | 1.33285128 |
| 73 | MP0005164_abnormal_response_to | 1.31720831 |
| 74 | MP0000490_abnormal_crypts_of | 1.30070121 |
| 75 | MP0004858_abnormal_nervous_system | 1.29978348 |
| 76 | MP0002452_abnormal_antigen_presenting | 1.28517813 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.23347937 |
| 78 | MP0008058_abnormal_DNA_repair | 1.22356053 |
| 79 | MP0008007_abnormal_cellular_replicative | 1.21622069 |
| 80 | MP0002723_abnormal_immune_serum | 1.21140334 |
| 81 | MP0002282_abnormal_trachea_morphology | 1.16334332 |
| 82 | MP0005058_abnormal_lysosome_morphology | 1.15939939 |
| 83 | MP0002269_muscular_atrophy | 1.14895940 |
| 84 | MP0008469_abnormal_protein_level | 1.13556094 |
| 85 | MP0001542_abnormal_bone_strength | 1.13088308 |
| 86 | MP0003448_altered_tumor_morphology | 1.12519846 |
| 87 | MP0001819_abnormal_immune_cell | 1.11006110 |
| 88 | MP0002420_abnormal_adaptive_immunity | 1.11002741 |
| 89 | MP0002896_abnormal_bone_mineralization | 1.10825373 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.09414456 |
| 91 | MP0003828_pulmonary_edema | 1.09141302 |
| 92 | MP0002933_joint_inflammation | 1.08006224 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.07736381 |
| 94 | MP0002060_abnormal_skin_morphology | 1.07175187 |
| 95 | MP0005390_skeleton_phenotype | 1.07050564 |
| 96 | MP0000733_abnormal_muscle_development | 1.06842626 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.06716854 |
| 98 | MP0001853_heart_inflammation | 1.06694345 |
| 99 | MP0003283_abnormal_digestive_organ | 1.06636686 |
| 100 | MP0003786_premature_aging | 1.05637787 |
| 101 | MP0003172_abnormal_lysosome_physiology | 1.05135295 |
| 102 | MP0003950_abnormal_plasma_membrane | 1.04364326 |
| 103 | MP0002019_abnormal_tumor_incidence | 1.03849483 |
| 104 | MP0009764_decreased_sensitivity_to | 1.02822571 |
| 105 | MP0000371_diluted_coat_color | 1.02723534 |
| 106 | MP0002405_respiratory_system_inflammati | 1.02495794 |
| 107 | MP0002111_abnormal_tail_morphology | 1.01893933 |
| 108 | MP0000313_abnormal_cell_death | 1.01603253 |
| 109 | MP0010155_abnormal_intestine_physiology | 1.00571578 |
| 110 | MP0004883_abnormal_blood_vessel | 0.99528280 |
| 111 | MP0005360_urolithiasis | 0.98052306 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.97117647 |
| 113 | MP0001800_abnormal_humoral_immune | 0.96538788 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95911194 |
| 115 | MP0003795_abnormal_bone_structure | 0.94872239 |
| 116 | MP0005166_decreased_susceptibility_to | 0.94046612 |
| 117 | MP0000750_abnormal_muscle_regeneration | 0.91279082 |
| 118 | MP0003806_abnormal_nucleotide_metabolis | 0.90484478 |
| 119 | MP0001849_ear_inflammation | 0.90181869 |
| 120 | MP0005165_increased_susceptibility_to | 0.89404153 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.88661877 |
| 122 | MP0002089_abnormal_postnatal_growth/wei | 0.88111482 |
| 123 | MP0000685_abnormal_immune_system | 0.87316125 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.85630594 |
| 125 | MP0002925_abnormal_cardiovascular_devel | 0.84686560 |
| 126 | MP0005671_abnormal_response_to | 0.84550089 |
| 127 | MP0002106_abnormal_muscle_physiology | 0.84328511 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.84006490 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.83618134 |
| 130 | MP0008438_abnormal_cutaneous_collagen | 0.82966224 |
| 131 | MP0000249_abnormal_blood_vessel | 0.82294001 |
| 132 | MP0006072_abnormal_retinal_apoptosis | 0.81969531 |
| 133 | MP0005623_abnormal_meninges_morphology | 0.81466946 |
| 134 | MP0000003_abnormal_adipose_tissue | 0.80261492 |
| 135 | MP0000858_altered_metastatic_potential | 0.79345553 |
| 136 | MP0004808_abnormal_hematopoietic_stem | 0.79020912 |
| 137 | MP0005409_darkened_coat_color | 0.78948982 |
| 138 | MP0001915_intracranial_hemorrhage | 0.78921219 |
| 139 | MP0003656_abnormal_erythrocyte_physiolo | 0.78680081 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.78488567 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.77944371 |
| 142 | MP0002697_abnormal_eye_size | 0.76803482 |
| 143 | MP0000343_altered_response_to | 0.76178171 |
| 144 | MP0000432_abnormal_head_morphology | 0.75091135 |
| 145 | MP0000716_abnormal_immune_system | 0.74409245 |
| 146 | MP0002249_abnormal_larynx_morphology | 0.74382846 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.74245849 |
| 148 | MP0002396_abnormal_hematopoietic_system | 0.74190352 |
| 149 | MP0001243_abnormal_dermal_layer | 0.73606162 |
| 150 | MP0000751_myopathy | 0.72181373 |
| 151 | MP0001216_abnormal_epidermal_layer | 0.72171801 |
| 152 | MP0000747_muscle_weakness | 0.72165482 |
| 153 | MP0001348_abnormal_lacrimal_gland | 0.71384665 |
| 154 | MP0008770_decreased_survivor_rate | 0.70655461 |
| 155 | MP0004264_abnormal_extraembryonic_tissu | 0.70429901 |
| 156 | MP0005083_abnormal_biliary_tract | 0.70313703 |
| 157 | MP0000266_abnormal_heart_morphology | 0.70187037 |
| 158 | MP0002139_abnormal_hepatobiliary_system | 0.70164575 |
| 159 | MP0002722_abnormal_immune_system | 0.69887516 |
| 160 | MP0003941_abnormal_skin_development | 0.68523802 |
| 161 | MP0002932_abnormal_joint_morphology | 0.68423353 |
| 162 | MP0005501_abnormal_skin_physiology | 0.68206294 |
| 163 | MP0002092_abnormal_eye_morphology | 0.67645004 |
| 164 | MP0006082_CNS_inflammation | 0.67463985 |
| 165 | MP0005595_abnormal_vascular_smooth | 0.66713502 |
| 166 | MP0000762_abnormal_tongue_morphology | 0.64350742 |
| 167 | MP0000703_abnormal_thymus_morphology | 0.64002672 |
| 168 | MP0005508_abnormal_skeleton_morphology | 0.63457470 |
| 169 | MP0002796_impaired_skin_barrier | 0.63300792 |
| 170 | MP0002398_abnormal_bone_marrow | 0.62848502 |
| 171 | MP0003935_abnormal_craniofacial_develop | 0.62388545 |
| 172 | MP0003385_abnormal_body_wall | 0.62057391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.36094784 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.24504388 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.24504388 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.24504388 |
| 5 | Rib fusion (HP:0000902) | 3.70365230 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.60812705 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 3.53393415 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.34637272 |
| 9 | Ulnar bowing (HP:0003031) | 3.31435517 |
| 10 | Selective tooth agenesis (HP:0001592) | 3.27548061 |
| 11 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.26011742 |
| 12 | Pustule (HP:0200039) | 3.25636966 |
| 13 | Rectal fistula (HP:0100590) | 3.25382980 |
| 14 | Rectovaginal fistula (HP:0000143) | 3.25382980 |
| 15 | Short humerus (HP:0005792) | 3.23749811 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.22919394 |
| 17 | Facial hemangioma (HP:0000329) | 3.14427520 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.08147656 |
| 19 | Cerebral aneurysm (HP:0004944) | 3.00438342 |
| 20 | Intestinal fistula (HP:0100819) | 2.98694830 |
| 21 | Concave nail (HP:0001598) | 2.96454882 |
| 22 | Annular pancreas (HP:0001734) | 2.93603965 |
| 23 | Vaginal fistula (HP:0004320) | 2.92083798 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 2.90465118 |
| 25 | Atrophic scars (HP:0001075) | 2.89186491 |
| 26 | Deep venous thrombosis (HP:0002625) | 2.82878141 |
| 27 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.78047701 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.78047701 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.78047701 |
| 30 | Absent radius (HP:0003974) | 2.76834969 |
| 31 | Recurrent bacterial skin infections (HP:0005406) | 2.69367399 |
| 32 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.68935945 |
| 33 | Ulnar deviation of the wrist (HP:0003049) | 2.68752910 |
| 34 | Peritonitis (HP:0002586) | 2.67202111 |
| 35 | Vertebral hypoplasia (HP:0008417) | 2.65239880 |
| 36 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.65239880 |
| 37 | Myocardial infarction (HP:0001658) | 2.63591058 |
| 38 | Poikiloderma (HP:0001029) | 2.62845126 |
| 39 | Axonal loss (HP:0003447) | 2.61276681 |
| 40 | Basal cell carcinoma (HP:0002671) | 2.60839069 |
| 41 | Achilles tendon contracture (HP:0001771) | 2.60782252 |
| 42 | Loss of speech (HP:0002371) | 2.55844804 |
| 43 | Absent forearm bone (HP:0003953) | 2.55222435 |
| 44 | Aplasia involving forearm bones (HP:0009822) | 2.55222435 |
| 45 | Abnormality of the calcaneus (HP:0008364) | 2.54839987 |
| 46 | Ependymoma (HP:0002888) | 2.52347770 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52090724 |
| 48 | Amyloidosis (HP:0011034) | 2.49938440 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49261220 |
| 50 | Congenital hip dislocation (HP:0001374) | 2.46156201 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.44857203 |
| 52 | Alopecia of scalp (HP:0002293) | 2.42239763 |
| 53 | Distal lower limb amyotrophy (HP:0008944) | 2.41586531 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.41177381 |
| 55 | Fragile skin (HP:0001030) | 2.38927478 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.38233645 |
| 57 | Arterial tortuosity (HP:0005116) | 2.38027895 |
| 58 | Absent thumb (HP:0009777) | 2.37082109 |
| 59 | Calcaneovalgus deformity (HP:0001848) | 2.36229152 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.36060362 |
| 61 | Spondylolisthesis (HP:0003302) | 2.35026028 |
| 62 | Cervical subluxation (HP:0003308) | 2.32213323 |
| 63 | Abnormality of the astrocytes (HP:0100707) | 2.30301271 |
| 64 | Astrocytoma (HP:0009592) | 2.30301271 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 2.29426687 |
| 66 | Vascular tortuosity (HP:0004948) | 2.28876936 |
| 67 | Nuclear cataract (HP:0100018) | 2.28755763 |
| 68 | Tongue fasciculations (HP:0001308) | 2.28286459 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.27615445 |
| 70 | Myoglobinuria (HP:0002913) | 2.27203894 |
| 71 | Abnormal number of incisors (HP:0011064) | 2.26009828 |
| 72 | Broad face (HP:0000283) | 2.24349187 |
| 73 | Orthostatic hypotension (HP:0001278) | 2.24329371 |
| 74 | Myositis (HP:0100614) | 2.24301608 |
| 75 | Aortic dissection (HP:0002647) | 2.24038965 |
| 76 | Turricephaly (HP:0000262) | 2.23160196 |
| 77 | Short nail (HP:0001799) | 2.23051528 |
| 78 | Muscle fibrillation (HP:0010546) | 2.22305591 |
| 79 | Round ear (HP:0100830) | 2.22255208 |
| 80 | Squamous cell carcinoma (HP:0002860) | 2.21203452 |
| 81 | Orchitis (HP:0100796) | 2.20302826 |
| 82 | Abnormality of abdominal situs (HP:0011620) | 2.18899852 |
| 83 | Abdominal situs inversus (HP:0003363) | 2.18899852 |
| 84 | Blue sclerae (HP:0000592) | 2.18271890 |
| 85 | Patellar aplasia (HP:0006443) | 2.16893377 |
| 86 | Rhabdomyolysis (HP:0003201) | 2.15710668 |
| 87 | Exercise-induced myalgia (HP:0003738) | 2.14747545 |
| 88 | Muscle fiber inclusion bodies (HP:0100299) | 2.14089921 |
| 89 | Deformed tarsal bones (HP:0008119) | 2.14078284 |
| 90 | Metaphyseal cupping (HP:0003021) | 2.13996510 |
| 91 | Thin bony cortex (HP:0002753) | 2.13702381 |
| 92 | Increased IgM level (HP:0003496) | 2.12422760 |
| 93 | Eczematoid dermatitis (HP:0000976) | 2.10342021 |
| 94 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.09652228 |
| 95 | Vertebral fusion (HP:0002948) | 2.09198950 |
| 96 | Hyperacusis (HP:0010780) | 2.08740663 |
| 97 | Cellulitis (HP:0100658) | 2.08661982 |
| 98 | Purpura (HP:0000979) | 2.08181048 |
| 99 | Abnormality of the aortic arch (HP:0012303) | 2.06884256 |
| 100 | Elbow flexion contracture (HP:0002987) | 2.06349518 |
| 101 | Agnosia (HP:0010524) | 2.06193949 |
| 102 | Ankle contracture (HP:0006466) | 2.05550993 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 2.05520707 |
| 104 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.04934763 |
| 105 | Flat acetabular roof (HP:0003180) | 2.04852785 |
| 106 | Increased serum ferritin (HP:0003281) | 2.04176788 |
| 107 | Albinism (HP:0001022) | 2.02236337 |
| 108 | Wormian bones (HP:0002645) | 2.01598262 |
| 109 | Trismus (HP:0000211) | 2.01406828 |
| 110 | Dilatation of the ascending aorta (HP:0005111) | 2.01395654 |
| 111 | Pathologic fracture (HP:0002756) | 2.00297637 |
| 112 | Gingivitis (HP:0000230) | 1.99289514 |
| 113 | Increased density of long bones (HP:0006392) | 1.97383200 |
| 114 | Distal upper limb amyotrophy (HP:0007149) | 1.95588050 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.95588050 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.95447794 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95340516 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.95340516 |
| 119 | Premature graying of hair (HP:0002216) | 1.94560323 |
| 120 | Male infertility (HP:0003251) | 1.94218683 |
| 121 | Myopathic facies (HP:0002058) | 1.92334885 |
| 122 | Abnormal hemoglobin (HP:0011902) | 1.91715730 |
| 123 | Coronal craniosynostosis (HP:0004440) | 1.90781512 |
| 124 | Natal tooth (HP:0000695) | 1.90290488 |
| 125 | Missing ribs (HP:0000921) | 1.89952568 |
| 126 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89624415 |
| 127 | Aneurysm (HP:0002617) | 1.88012560 |
| 128 | Nemaline bodies (HP:0003798) | 1.84216986 |
| 129 | Mitral stenosis (HP:0001718) | 1.84196900 |
| 130 | Bone pain (HP:0002653) | 1.83935473 |
| 131 | Spinal rigidity (HP:0003306) | 1.83794110 |
| 132 | Glomerulonephritis (HP:0000099) | 1.83741251 |
| 133 | Disproportionate tall stature (HP:0001519) | 1.82994160 |
| 134 | Abnormality of complement system (HP:0005339) | 1.82474728 |
| 135 | Xanthomatosis (HP:0000991) | 1.81855922 |
| 136 | Increased connective tissue (HP:0009025) | 1.81561891 |
| 137 | Aortic aneurysm (HP:0004942) | 1.81413464 |
| 138 | Abnormal ossification of hand bones (HP:0005921) | 1.81065094 |
| 139 | Malnutrition (HP:0004395) | 1.80287524 |
| 140 | Bowing of the arm (HP:0006488) | 1.80095563 |
| 141 | Bowed forearm bones (HP:0003956) | 1.80095563 |
| 142 | Abnormality of the labia minora (HP:0012880) | 1.78586112 |
| 143 | Abnormality of carpal bone ossification (HP:0006257) | 1.76974351 |
| 144 | Mitral regurgitation (HP:0001653) | 1.76572438 |
| 145 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75206286 |
| 146 | Obstructive lung disease (HP:0006536) | 1.75206286 |
| 147 | Type 1 muscle fiber predominance (HP:0003803) | 1.74684213 |
| 148 | Broad thumb (HP:0011304) | 1.74557662 |
| 149 | Protrusio acetabuli (HP:0003179) | 1.73900653 |
| 150 | Bladder diverticulum (HP:0000015) | 1.73810903 |
| 151 | Intestinal atresia (HP:0011100) | 1.73629958 |
| 152 | Distal arthrogryposis (HP:0005684) | 1.72874845 |
| 153 | Muscle stiffness (HP:0003552) | 1.72213668 |
| 154 | Recurrent abscess formation (HP:0002722) | 1.72185123 |
| 155 | Interstitial pulmonary disease (HP:0006530) | 1.71738488 |
| 156 | Genu recurvatum (HP:0002816) | 1.70925896 |
| 157 | Cheilitis (HP:0100825) | 1.70910384 |
| 158 | Joint stiffness (HP:0001387) | 1.70604424 |
| 159 | Broad alveolar ridges (HP:0000187) | 1.70390229 |
| 160 | Abnormality of the acetabulum (HP:0003170) | 1.70146720 |
| 161 | Generalized amyotrophy (HP:0003700) | 1.69260584 |
| 162 | Coxa vara (HP:0002812) | 1.68821071 |
| 163 | Polycythemia (HP:0001901) | 1.67616122 |
| 164 | Difficulty climbing stairs (HP:0003551) | 1.67411727 |
| 165 | Mediastinal lymphadenopathy (HP:0100721) | 1.66492546 |
| 166 | Hepatosplenomegaly (HP:0001433) | 1.65929065 |
| 167 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65728361 |
| 168 | Biconcave vertebral bodies (HP:0004586) | 1.64731187 |
| 169 | Hypotelorism (HP:0000601) | 1.64271662 |
| 170 | Ovoid vertebral bodies (HP:0003300) | 1.64016306 |
| 171 | Hypertriglyceridemia (HP:0002155) | 1.63715872 |
| 172 | Fused cervical vertebrae (HP:0002949) | 1.63573402 |
| 173 | Diaphragmatic weakness (HP:0009113) | 1.63229261 |
| 174 | Choanal stenosis (HP:0000452) | 1.63177161 |
| 175 | Short 5th finger (HP:0009237) | 1.62388734 |
| 176 | Rhabdomyosarcoma (HP:0002859) | 1.61601071 |
| 177 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61057856 |
| 178 | Mucopolysacchariduria (HP:0008155) | 1.61057856 |
| 179 | Deviation of the thumb (HP:0009603) | 1.60478764 |
| 180 | Breast hypoplasia (HP:0003187) | 1.60342819 |
| 181 | Abnormality of the anterior horn cell (HP:0006802) | 1.60060970 |
| 182 | Degeneration of anterior horn cells (HP:0002398) | 1.60060970 |
| 183 | Neoplasm of the oral cavity (HP:0100649) | 1.59932316 |
| 184 | Hypochromic anemia (HP:0001931) | 1.59445808 |
| 185 | Reticulocytopenia (HP:0001896) | 1.59082840 |
| 186 | Spinal muscular atrophy (HP:0007269) | 1.58907305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 3.97116774 |
| 2 | IRAK3 | 3.19557649 |
| 3 | DDR2 | 3.13568105 |
| 4 | MAP3K11 | 3.01337097 |
| 5 | PKN2 | 2.78498203 |
| 6 | FGR | 2.37842729 |
| 7 | BMX | 2.30370821 |
| 8 | SIK1 | 2.25469692 |
| 9 | TGFBR2 | 2.24718812 |
| 10 | PRPF4B | 2.15773083 |
| 11 | MAP3K6 | 2.11464251 |
| 12 | MST1R | 2.05601151 |
| 13 | CDK12 | 2.03791098 |
| 14 | MAP3K10 | 1.96673412 |
| 15 | TRIB3 | 1.96098291 |
| 16 | CDK7 | 1.95660702 |
| 17 | CDC7 | 1.88862807 |
| 18 | CSK | 1.83822123 |
| 19 | NEK2 | 1.80748270 |
| 20 | SMG1 | 1.80258628 |
| 21 | BUB1 | 1.80258158 |
| 22 | MATK | 1.77803139 |
| 23 | TYRO3 | 1.64701427 |
| 24 | WEE1 | 1.63591886 |
| 25 | STK10 | 1.63571998 |
| 26 | EPHB1 | 1.62643142 |
| 27 | PIM2 | 1.59554976 |
| 28 | NEK1 | 1.59226075 |
| 29 | FLT3 | 1.58377946 |
| 30 | PDGFRA | 1.56996493 |
| 31 | EEF2K | 1.55332658 |
| 32 | MAP3K13 | 1.51425054 |
| 33 | MAPK15 | 1.49355363 |
| 34 | MAP3K14 | 1.47734572 |
| 35 | TTN | 1.47673490 |
| 36 | IRAK4 | 1.46257829 |
| 37 | CDK6 | 1.44608476 |
| 38 | PAK4 | 1.43920212 |
| 39 | ZAP70 | 1.43496488 |
| 40 | PIM1 | 1.39775045 |
| 41 | TBK1 | 1.36060297 |
| 42 | RIPK4 | 1.32833448 |
| 43 | DYRK1B | 1.32579022 |
| 44 | MOS | 1.30611981 |
| 45 | FGFR4 | 1.28570385 |
| 46 | TESK2 | 1.27590759 |
| 47 | ALK | 1.27309453 |
| 48 | ARAF | 1.24105037 |
| 49 | MAP3K8 | 1.20515993 |
| 50 | MAP2K3 | 1.19619364 |
| 51 | RPS6KB2 | 1.17944110 |
| 52 | TLK1 | 1.16991515 |
| 53 | LATS2 | 1.16763286 |
| 54 | YES1 | 1.14855721 |
| 55 | PLK1 | 1.14078405 |
| 56 | TRPM7 | 1.11139799 |
| 57 | EPHB2 | 1.11003338 |
| 58 | EPHA2 | 1.07667713 |
| 59 | UHMK1 | 1.06334703 |
| 60 | PRKD2 | 1.06127210 |
| 61 | MAP3K1 | 1.05584400 |
| 62 | BLK | 1.05157803 |
| 63 | RPS6KL1 | 1.04878966 |
| 64 | RPS6KC1 | 1.04878966 |
| 65 | LIMK1 | 1.03603244 |
| 66 | PDPK1 | 1.00869111 |
| 67 | NEK9 | 0.98694384 |
| 68 | MTOR | 0.97767620 |
| 69 | DAPK1 | 0.94653699 |
| 70 | JAK3 | 0.94308836 |
| 71 | FGFR1 | 0.93874359 |
| 72 | TTK | 0.93266767 |
| 73 | CSF1R | 0.90310606 |
| 74 | ABL2 | 0.90307109 |
| 75 | RPS6KA6 | 0.89494092 |
| 76 | PTK2 | 0.88435459 |
| 77 | CDK4 | 0.88146306 |
| 78 | ATR | 0.87187584 |
| 79 | KSR2 | 0.87030288 |
| 80 | RPS6KA2 | 0.86125666 |
| 81 | EIF2AK1 | 0.85262485 |
| 82 | PRKG2 | 0.85181126 |
| 83 | CHEK2 | 0.82079117 |
| 84 | PHKG1 | 0.81615470 |
| 85 | PHKG2 | 0.81615470 |
| 86 | SIK2 | 0.79058618 |
| 87 | LRRK2 | 0.78660474 |
| 88 | RIPK1 | 0.74759169 |
| 89 | MAPK11 | 0.74618867 |
| 90 | STK38 | 0.72923647 |
| 91 | TAOK2 | 0.72917202 |
| 92 | NTRK1 | 0.72802604 |
| 93 | DMPK | 0.71361634 |
| 94 | RPS6KA1 | 0.70680978 |
| 95 | GRK7 | 0.70200294 |
| 96 | AURKB | 0.69790081 |
| 97 | STK4 | 0.69404931 |
| 98 | PINK1 | 0.69316159 |
| 99 | AURKA | 0.68079411 |
| 100 | SCYL2 | 0.68021188 |
| 101 | GSK3A | 0.67525008 |
| 102 | MARK2 | 0.67342410 |
| 103 | CHEK1 | 0.66820108 |
| 104 | ERN1 | 0.65109432 |
| 105 | OBSCN | 0.64668633 |
| 106 | CDK2 | 0.64445160 |
| 107 | PTK6 | 0.62700287 |
| 108 | PAK1 | 0.62490988 |
| 109 | MAP4K1 | 0.61182632 |
| 110 | NME2 | 0.60219625 |
| 111 | DYRK3 | 0.59229759 |
| 112 | RPS6KA4 | 0.58613118 |
| 113 | STK3 | 0.58488503 |
| 114 | SIK3 | 0.57617829 |
| 115 | MAPKAPK3 | 0.57600308 |
| 116 | PDGFRB | 0.56396176 |
| 117 | PLK4 | 0.56302988 |
| 118 | JAK1 | 0.55998126 |
| 119 | PDK1 | 0.54384889 |
| 120 | HCK | 0.53908430 |
| 121 | EGFR | 0.52400704 |
| 122 | CDC42BPA | 0.51110879 |
| 123 | LMTK2 | 0.50541847 |
| 124 | TESK1 | 0.50431995 |
| 125 | ATM | 0.50403613 |
| 126 | AKT2 | 0.49598596 |
| 127 | MAP3K3 | 0.49133468 |
| 128 | IKBKB | 0.48741819 |
| 129 | MET | 0.46052678 |
| 130 | PAK2 | 0.45536743 |
| 131 | MAPKAPK2 | 0.43804199 |
| 132 | PDK2 | 0.43217879 |
| 133 | GRK6 | 0.42201521 |
| 134 | TYK2 | 0.41908033 |
| 135 | CSNK2A1 | 0.41726744 |
| 136 | BRAF | 0.41599847 |
| 137 | MAPK12 | 0.39817072 |
| 138 | TAOK1 | 0.39729594 |
| 139 | IRAK2 | 0.39498551 |
| 140 | MAP3K9 | 0.38179615 |
| 141 | LYN | 0.36798680 |
| 142 | ERBB4 | 0.36711710 |
| 143 | MAP2K6 | 0.36530199 |
| 144 | CLK1 | 0.36353726 |
| 145 | CSNK2A2 | 0.35960620 |
| 146 | MAPK1 | 0.35043393 |
| 147 | MAP3K7 | 0.33341857 |
| 148 | HIPK2 | 0.30910835 |
| 149 | LCK | 0.30582946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 3.76851758 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.65284016 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.63190355 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.18072650 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.77170286 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.36656566 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.36514416 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.36509358 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.27560232 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.05936048 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 1.89909681 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.87053027 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85100989 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.80863667 |
| 15 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.80321251 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 1.75759173 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.75529786 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68378568 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.67071559 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56657809 |
| 21 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.55190386 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.54502492 |
| 23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.50471478 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.47617883 |
| 25 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.44678833 |
| 26 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.44343571 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.43972200 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.43810931 |
| 29 | Amoebiasis_Homo sapiens_hsa05146 | 1.43160233 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42903523 |
| 31 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.40906838 |
| 32 | Legionellosis_Homo sapiens_hsa05134 | 1.40223163 |
| 33 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.35114097 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.34736589 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.34688582 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.33644230 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31986028 |
| 38 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31332147 |
| 39 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.29630294 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29063709 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27999181 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26823282 |
| 43 | Prion diseases_Homo sapiens_hsa05020 | 1.26417664 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22024076 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16220651 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16144809 |
| 47 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.16057800 |
| 48 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.09655125 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08435982 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07557391 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06792753 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.06100689 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03940255 |
| 54 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.03389279 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03096599 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.02697734 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00218428 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99946806 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.99446007 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99038522 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98408961 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96735821 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96171141 |
| 64 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.95605360 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.95118382 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.93919658 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.93913038 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93673743 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.93526730 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90702802 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.90649965 |
| 72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90250782 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.89443696 |
| 74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89355642 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89228085 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88225908 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86876407 |
| 78 | RNA polymerase_Homo sapiens_hsa03020 | 0.86228748 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85297717 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85103504 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82740744 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81183872 |
| 83 | Proteasome_Homo sapiens_hsa03050 | 0.80231187 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80072731 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.78608723 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78133336 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77991137 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77577884 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77523821 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77045101 |
| 91 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76032734 |
| 92 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.75010874 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73025978 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72901700 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72822940 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.72696766 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.72673856 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70249942 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68180470 |
| 100 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.67944362 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67302489 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66872918 |
| 103 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66026743 |
| 104 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.65360962 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63785936 |
| 106 | Allograft rejection_Homo sapiens_hsa05330 | 0.62468529 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.62261283 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61499981 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.61018401 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.60891848 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60805360 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.60607330 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.60200561 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59109262 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.57598062 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57451638 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57309168 |
| 118 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57183082 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56925361 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56800756 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.56502134 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55815931 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54938169 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54248765 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53696448 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53331250 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52435009 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51812653 |
| 129 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50897000 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50545007 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49358135 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49355674 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48409697 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48385996 |
| 135 | Mineral absorption_Homo sapiens_hsa04978 | 0.46144651 |
| 136 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45281345 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45058006 |
| 138 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45040490 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.42250657 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40393904 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40152389 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38654173 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.38271244 |
| 144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38215672 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37391197 |
| 146 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37384570 |
| 147 | Malaria_Homo sapiens_hsa05144 | 0.36976328 |
| 148 | Prostate cancer_Homo sapiens_hsa05215 | 0.36178620 |
| 149 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35921281 |

